These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8988123)

  • 1. Old-world leishmaniasis of the auricle.
    Skevas A; Kastanioudakis I; Bai M; Kostoula A
    Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
    El kartouti A; Elbenaye J; Miloudi M
    Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
    Sousa AQ; Pompeu MM; Sólon FR; Frutuoso MS; Teixeira MJ; Silva TM
    Braz J Infect Dis; 2006 Jun; 10(3):230. PubMed ID: 17568857
    [No Abstract]   [Full Text] [Related]  

  • 5. Leishmaniasis of the lip.
    Veraldi S; Rigoni C; Gianotti R
    Acta Derm Venereol; 2002; 82(6):469-70. PubMed ID: 12575860
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome.
    Nogueira-Castañon MC; Pereira CA; Furtado T
    Int J Dermatol; 1996 Apr; 35(4):295-7. PubMed ID: 8786193
    [No Abstract]   [Full Text] [Related]  

  • 7. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
    Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
    Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strange infiltrative plaque on the face.
    Guarneri C; Wollina U; Chokoeva A; Lotti TM; Tchernev G
    Braz J Infect Dis; 2016; 20(2):214-5. PubMed ID: 26748228
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.
    Sgarbi IM; Santos FD; Monteiro VE; Fonseca SN; Bernardes Filho F
    Braz J Infect Dis; 2017; 21(2):201-202. PubMed ID: 28012931
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergency initiative to reduce leishmaniasis in Afghanistan.
    Querido J
    Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oriental sore: a case report.
    Asvesti C; Anastassiadis G; Kolokotronis A; Zographakis I
    Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):56-8. PubMed ID: 1603565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony.
    de Oliveira-Neto MP; Mattos Mda S
    Rev Soc Bras Med Trop; 2006; 39(4):376-8. PubMed ID: 17119754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).
    Grimaldi G; Porrozzi R; Friedrich K; Teva A; Marchevsky RS; Vieira F; Miekeley N; Paumgartten FJ
    Antimicrob Agents Chemother; 2010 Jan; 54(1):502-5. PubMed ID: 19822700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate].
    Rodrigues AM; Hueb M; Santos TA; Fontes CJ
    Rev Soc Bras Med Trop; 2006; 39(2):139-45. PubMed ID: 16699638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon gamma therapy for cutaneous leishmaniasis.
    Kürkçüoğlu N; Tandoğdu R
    Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous leishmaniasis: an overview.
    Hepburn NC
    J Postgrad Med; 2003; 49(1):50-4. PubMed ID: 12865571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.